Diagnostic validation of a novel high-sensitivity cardiac troponin T assay
European Heart Journal: Acute Cardiovascular Care · 08.07.2026 · 15 (7) · 535-544
DOI: 10.1093/ehjacc/zuag044 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 20.04.2026. Verfasst von Ben Völschow und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg 20246…. Hauptthemen laut MEDLINE: Troponin T, Non-ST Elevated Myocardial Infarction, Myocardial Infarction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche, Abbott, PHC.
Abstract (Originalsprache)
Aims
High-sensitivity cardiac troponin (hs-cTn) assays are integral to evaluating suspected myocardial infarction (MI). A recently developed hs-cTnT assay requires diagnostic and prognostic evaluation. Methods and results Patients presenting to the emergency department with suspected non-ST-elevation MI were prospectively evaluated. Discrimination was tested using the area under the curve (AUC). Diagnostic performance was assessed with previously derived cut-off concentrations and ESC 0/1 h algorithm. Head-to-head comparisons between the new and established assays were performed. Prognostic performance of hs-cTnT for 1-year mortality and major adverse cardiac events (MACE) was analysed using adjusted Cox regression. In 1415 patients, mean age 64 years and 64.2% male, MI was diagnosed in 12.1%. The novel TnT hs Gen 6 assay demonstrated excellent discrimination with an AUC on admission of 0.87 (95% CI: 0.84, 0.90) and 0.91 (95% CI: 0.89, 0.93) after 1 h. Using a 0 h cut-off <8 ng/L or <18 ng/L and Δ 0/1 h of <2 ng/L enabled rule-out in 54.3% (95% CI: 51.7%, 57.0%), with a NPV of 99.5% (95% CI: 98.7%, 99.9%); sensitivity was 97.7% (95% CI: 94.1%, 99.4%). For rule-in, a 0 h cut-off ≥112 ng/L or a Δ 0/1 h ≥ 10 ng/L yielded a PPV of 58.5% (95% CI: 51.9%, 64.9%) and specificity of 92.2% (95% CI: 90.6%, 93.6%) with rule-in of 16.5% (95% CI: 14.6%, 18.6%). Hs-cTnT was associated with 1-year mortality [hazard ratio (HR) 1.39 (95% CI: 1.28, 1.51)] and MACE [HR 1.22 (95% CI: 1.15, 1.29)].
Conclusion
The novel hs-cTnT assay demonstrates high diagnostic accuracy to rule-out or diagnose MI and offers valuable prognostic information regarding 1-year mortality and MACE. Trial Registration: clinicaltrials.gov (NCT02355457)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistrasse 52, Hamburg 20246, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Martinistrasse 52, Hamburg 20246, Germany.
- Department for Internal Medicine II, Division of Cardiology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
- University Institute of Clinical Chemistry and Laboratory Medicine, University Oldenburg, Rahel-Straus-Straße 10, Oldenburg 26133, Germany.
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, Greifswald 17489, Germany.
- Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC 3004, Australia.
ORCID-Profile: Ben Völschow, Betül Toprak, Raphael Twerenbold
Förderung
- Roche
- Abbott
- PHC
- Roche Diagnostics
- Siemens Healthineers
- German Research Foundation
- ART-EMIS Hamburg GmbH
- German Center for Cardiovascular Research
Zitieren
APA
Völschow, B., Strauß, B., Sörensen, N. A., Thießen, N., Lehmacher, J., Toprak, B., Abdennadher, B., Dehkordi, F., Haller, P. M., Scharlemann, L., Schock, A., Petersmann, A., Gauß, F., Twerenbold, R., & Neumann, J. T. (2026). Diagnostic validation of a novel high-sensitivity cardiac troponin T assay. European Heart Journal: Acute Cardiovascular Care, 15(7), 535-544. https://doi.org/10.1093/ehjacc/zuag044
Vancouver
Völschow B, Strauß B, Sörensen NA, Thießen N, Lehmacher J, Toprak B, et al. Diagnostic validation of a novel high-sensitivity cardiac troponin T assay. European Heart Journal: Acute Cardiovascular Care. 2026;15(7):535-544. doi:10.1093/ehjacc/zuag044
BibTeX
@article{Vlschow2026,
author = {Völschow, Ben and Strauß, Bianca and Sörensen, Nils Arne and Thießen, Niklas and Lehmacher, Jonas and Toprak, Betül and Abdennadher, Beya and Dehkordi, Farnaz and Haller, Paul M and Scharlemann, Lea and Schock, Alina and Petersmann, Astrid and Gauß, Friederike and Twerenbold, Raphael and Neumann, Johannes T},
title = {Diagnostic validation of a novel high-sensitivity cardiac troponin T assay},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2026},
volume = {15},
number = {7},
pages = {535--544},
doi = {10.1093/ehjacc/zuag044}
}
EUVIMED